About
NRx Pharmaceuticals is a clinical biopharmaceutical company developing treatments focused on severe bipolar depression, suicidality, and PTSD, with lead investigational therapies NRX-100 (ketamine) and NRX-101 currently in FDA clinical trials.
Explore NRx Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.